annual current liabilities:
$120.68M+$44.62M(+58.66%)Summary
- As of today (July 1, 2025), CPRX annual total current liabilities is $120.68 million, with the most recent change of +$44.62 million (+58.66%) on December 31, 2024.
- During the last 3 years, CPRX annual current liabilities has risen by +$93.61 million (+345.92%).
- CPRX annual current liabilities is now at all-time high.
Performance
CPRX Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$111.65M-$9.03M(-7.48%)Summary
- As of today (July 1, 2025), CPRX quarterly total current liabilities is $111.65 million, with the most recent change of -$9.03 million (-7.48%) on March 31, 2025.
- Over the past year, CPRX quarterly current liabilities has increased by +$32.08 million (+40.32%).
- CPRX quarterly current liabilities is now -7.48% below its all-time high of $120.68 million, reached on December 31, 2024.
Performance
CPRX quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
CPRX Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +58.7% | +40.3% |
| 3 y3 years | +345.9% | +386.7% |
| 5 y5 years | +400.8% | +533.1% |
CPRX Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +345.9% | -7.5% | +396.5% |
| 5 y | 5-year | at high | +430.3% | -7.5% | +673.4% |
| alltime | all time | at high | >+9999.0% | -7.5% | >+9999.0% |
CPRX Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $111.65M(-7.5%) |
| Dec 2024 | $120.68M(+58.7%) | $120.68M(+14.5%) |
| Sep 2024 | - | $105.39M(+14.2%) |
| Jun 2024 | - | $92.32M(+16.0%) |
| Mar 2024 | - | $79.57M(+4.6%) |
| Dec 2023 | $76.06M(+32.1%) | $76.06M(+31.6%) |
| Sep 2023 | - | $57.81M(+10.1%) |
| Jun 2023 | - | $52.50M(-7.4%) |
| Mar 2023 | - | $56.71M(-1.5%) |
| Dec 2022 | $57.59M(+112.8%) | $57.59M(+28.9%) |
| Sep 2022 | - | $44.68M(+98.7%) |
| Jun 2022 | - | $22.49M(-2.0%) |
| Mar 2022 | - | $22.94M(-15.2%) |
| Dec 2021 | $27.06M(+18.9%) | $27.06M(+31.3%) |
| Sep 2021 | - | $20.61M(+27.8%) |
| Jun 2021 | - | $16.14M(+11.8%) |
| Mar 2021 | - | $14.44M(-36.6%) |
| Dec 2020 | $22.76M(-5.6%) | $22.76M(+24.8%) |
| Sep 2020 | - | $18.23M(-9.8%) |
| Jun 2020 | - | $20.21M(+14.6%) |
| Mar 2020 | - | $17.64M(-26.8%) |
| Dec 2019 | $24.10M(+153.4%) | $24.10M(+34.0%) |
| Sep 2019 | - | $17.98M(+27.1%) |
| Jun 2019 | - | $14.15M(+56.8%) |
| Mar 2019 | - | $9.03M(-5.1%) |
| Dec 2018 | $9.51M(+122.9%) | $9.51M(+174.2%) |
| Sep 2018 | - | $3.47M(+12.5%) |
| Jun 2018 | - | $3.08M(+12.8%) |
| Mar 2018 | - | $2.73M(-36.0%) |
| Dec 2017 | $4.27M(+103.7%) | $4.27M(+55.8%) |
| Sep 2017 | - | $2.74M(+48.8%) |
| Jun 2017 | - | $1.84M(-3.4%) |
| Mar 2017 | - | $1.91M(-9.0%) |
| Dec 2016 | $2.09M(-39.1%) | $2.09M(+5.0%) |
| Sep 2016 | - | $2.00M(-13.4%) |
| Jun 2016 | - | $2.31M(-13.5%) |
| Mar 2016 | - | $2.66M(-22.6%) |
| Dec 2015 | $3.44M | $3.44M(+44.2%) |
| Sep 2015 | - | $2.39M(-6.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $2.55M(-56.3%) |
| Mar 2015 | - | $5.85M(-0.1%) |
| Dec 2014 | $5.86M(+173.6%) | $5.86M(-1.4%) |
| Sep 2014 | - | $5.94M(+151.2%) |
| Jun 2014 | - | $2.36M(-3.0%) |
| Mar 2014 | - | $2.44M(+13.9%) |
| Dec 2013 | $2.14M(+29.9%) | $2.14M(-29.0%) |
| Sep 2013 | - | $3.01M(+83.9%) |
| Jun 2013 | - | $1.64M(+66.6%) |
| Mar 2013 | - | $983.20K(-40.3%) |
| Dec 2012 | $1.65M(+97.5%) | $1.65M(+118.6%) |
| Sep 2012 | - | $753.30K(+11.3%) |
| Jun 2012 | - | $677.00K(-23.0%) |
| Mar 2012 | - | $879.30K(+5.5%) |
| Dec 2011 | $833.80K(+178.9%) | $833.80K(+97.3%) |
| Sep 2011 | - | $422.70K(-35.6%) |
| Jun 2011 | - | $656.10K(-23.9%) |
| Mar 2011 | - | $862.30K(+188.4%) |
| Dec 2010 | $299.00K(+1.6%) | $299.00K(-24.5%) |
| Sep 2010 | - | $396.10K(-12.2%) |
| Jun 2010 | - | $451.20K(+34.8%) |
| Mar 2010 | - | $334.70K(+13.8%) |
| Dec 2009 | $294.20K(-79.4%) | $294.20K(+10.7%) |
| Sep 2009 | - | $265.70K(-43.6%) |
| Jun 2009 | - | $470.90K(-69.4%) |
| Mar 2009 | - | $1.54M(+7.5%) |
| Dec 2008 | $1.43M(+371.5%) | $1.43M(+17.2%) |
| Sep 2008 | - | $1.22M(+64.9%) |
| Jun 2008 | - | $740.10K(+68.9%) |
| Mar 2008 | - | $438.10K(+44.4%) |
| Dec 2007 | $303.30K(-60.8%) | $303.30K(-25.1%) |
| Sep 2007 | - | $405.10K(-3.2%) |
| Jun 2007 | - | $418.50K(-20.2%) |
| Mar 2007 | - | $524.30K(-32.2%) |
| Dec 2006 | $772.80K(+125.3%) | $772.80K(+12.6%) |
| Sep 2006 | - | $686.50K(+58.0%) |
| Jun 2006 | - | $434.40K(+26.6%) |
| Dec 2005 | $343.00K(+405.9%) | $343.00K(+405.9%) |
| Dec 2004 | $67.80K | $67.80K |
FAQ
- What is Catalyst Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual current liabilities year-on-year change?
- What is Catalyst Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly current liabilities year-on-year change?
What is Catalyst Pharmaceuticals annual total current liabilities?
The current annual current liabilities of CPRX is $120.68M
What is the all time high annual current liabilities for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual total current liabilities is $120.68M
What is Catalyst Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, CPRX annual total current liabilities has changed by +$44.62M (+58.66%)
What is Catalyst Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of CPRX is $111.65M
What is the all time high quarterly current liabilities for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly total current liabilities is $120.68M
What is Catalyst Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, CPRX quarterly total current liabilities has changed by +$32.08M (+40.32%)